Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,527 | 35,436 | 52,236 | 44,998 | 31,388 |
| Receivables | 147,629 | 147,884 | 150,307 | 132,781 | 108,030 |
| Inventories | 186,409 | 174,043 | 167,111 | 201,901 | 93,174 |
| Other current assets | 1,209 | 1,161 | 1,148 | 1,508 | 1,557 |
| TOTAL | $403,912 | $385,150 | $392,911 | $404,248 | $256,653 |
| Non-Current Assets | |||||
| PPE Net | 362,036 | 360,282 | 364,806 | 376,121 | 222,011 |
| Intangibles | 407,084 | 395,048 | 396,430 | 421,022 | 287,737 |
| Other Non-Current Assets | 69,342 | 23,049 | 55,501 | 56,692 | 40,105 |
| TOTAL | $838,462 | $778,379 | $816,737 | $853,835 | $549,853 |
| Total Assets | $1,242,374 | $1,163,529 | $1,209,648 | $1,258,083 | $806,506 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 452,372 | 34,206 | 36,432 | 35,841 | 13,082 |
| Accounts payable and accrued liabilities | 116,919 | 108,894 | 122,210 | 127,378 | 72,479 |
| Accrued Expenses | 958 | 769 | 680 | 380 | 436 |
| Other current liabilities | N/A | N/A | N/A | N/A | 6,401 |
| TOTAL | $592,659 | $167,012 | $175,518 | $182,543 | $102,715 |
| Non-Current Liabilities | |||||
| Long Term Debt | 195,591 | 607,246 | 604,476 | 606,112 | 370,798 |
| Deferred Revenues | 20,188 | 19,516 | 13,370 | 14,782 | 10,317 |
| Other Non-Current Liabilities | 99,251 | 52,073 | 86,845 | 84,042 | 47,794 |
| TOTAL | $332,692 | $699,718 | $735,148 | $737,542 | $440,859 |
| Total Liabilities | $925,351 | $866,730 | $910,666 | $920,085 | $543,574 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,119 | 42,932 | 42,941 | 42,891 | 42,870 |
| Common Shares | 486 | 486 | 485 | 485 | 413 |
| Retained earnings | -13,777 | -3,532 | 7,160 | 22,571 | 45,996 |
| Other shareholders' equity | -6,570 | -32,637 | -40,159 | -14,352 | -18,363 |
| TOTAL | $317,023 | $296,799 | $298,982 | $337,998 | $262,932 |
| Total Liabilities And Equity | $1,242,374 | $1,163,529 | $1,209,648 | $1,258,083 | $806,506 |